| 1 | United Therapeutics Corporation US91307C1027 | 🇺🇸 US | $24,1 Mrd. | A+ |
| 2 | Incyte Corporation US45337C1027 | 🇺🇸 US | $19,0 Mrd. | A+ |
| 3 | Royalty Pharma plc GB00BMVP7Y09 | 🇺🇸 US | $22,4 Mrd. | A+ |
| 4 | Neurocrine Biosciences Inc. US64125C1099 | 🇺🇸 US | $15,8 Mrd. | A+ |
| 5 | ALK-Abelló A/S DK0061802139 | 🇩🇰 DK | $8,6 Mrd. | A+ |
| 6 | Exelixis Inc. US30161Q1040 | 🇺🇸 US | $12,5 Mrd. | A+ |
| 7 | Regeneron Pharmaceuticals Inc. US75886F1075 | 🇺🇸 US | $64,9 Mrd. | A+ |
| 8 | UCB S.A. BE0003739530 | 🇧🇪 BE | $51,0 Mrd. | A+ |
| 9 | Catalyst Pharmaceuticals Inc. US14888U1016 | 🇺🇸 US | $3,8 Mrd. | A+ |
| 10 | Ligand Pharmaceuticals Incorporated US53220K5048 | 🇺🇸 US | $4,2 Mrd. | A+ |
| 11 | Ascendis Pharma A/S DK0060615755 | 🇩🇰 DK | $14,7 Mrd. | A |
| 12 | Aurinia Pharmaceuticals Inc. CA05156V1022 | 🇨🇦 CA | $2,0 Mrd. | A |
| 13 | Sunshine Guojian Pharmaceutical (Shanghai) Co. Ltd CNE1000062X2 | 🇨🇳 CN | $7,8 Mrd. | A |
| 14 | Innoviva Inc. US45781M1018 | 🇺🇸 US | $1,6 Mrd. | A |
| 15 | Genmab A/S US3723032062 | 🇩🇰 DK | $16,2 Mrd. | A |
| 16 | Vertex Pharmaceuticals Incorporated US92532F1003 | 🇺🇸 US | $110,8 Mrd. | A |
| 17 | TG Therapeutics Inc. US88322Q1085 | 🇺🇸 US | $6,0 Mrd. | A |
| 18 | Krystal Biotech Inc. US5011471027 | 🇺🇸 US | $8,6 Mrd. | A |
| 19 | Amicus Therapeutics Inc. US03152W1099 | 🇺🇸 US | $4,5 Mrd. | A |
| 20 | Halozyme Therapeutics Inc. US40637H1095 | 🇺🇸 US | $8,0 Mrd. | A |
| 21 | Apellis Pharmaceuticals Inc. US03753U1060 | 🇺🇸 US | $5,3 Mrd. | A |
| 22 | 3SBio Inc. KYG8875G1029 | 🇨🇳 CN | $6,3 Mrd. | A |
| 23 | WuXi Biologics (Cayman) Inc. KYG970081173 | 🇨🇳 CN | $17,6 Mrd. | A |
| 24 | argenx SE NL0010832176 | 🇳🇱 NL | $48,7 Mrd. | A |
| 25 | Liquidia Corporation US53635D2027 | 🇺🇸 US | $5,1 Mrd. | B+ |
| 26 | Simcere Pharmaceutical Group Limited HK0000658531 | 🇨🇳 CN | $3,7 Mrd. | B+ |
| 27 | Zevra Therapeutics Inc. US4884452065 | 🇺🇸 US | $617 Mio. | B+ |
| 28 | Kiniksa Pharmaceuticals Ltd. GB00BRXB0C07 | 🇧🇲 BM | $4,0 Mrd. | B+ |
| 29 | Alkermes plc IE00B56GVS15 | 🇮🇪 IE | $6,2 Mrd. | B+ |
| 30 | ACADIA Pharmaceuticals Inc. US0042251084 | 🇺🇸 US | $3,5 Mrd. | B+ |
| 31 | Shanghai Allist Pharmaceuticals Co. Ltd. CNE100005XJ7 | 🇨🇳 CN | $6,0 Mrd. | B+ |
| 32 | BeOne Medicines AG CH1391448177 | 🇨🇭 CH | $30,8 Mrd. | B+ |
| 33 | Samsung Biologics Co.Ltd. KR7207940008 | 🇰🇷 KR | $41,7 Mrd. | B+ |
| 34 | Harmony Biosciences Holdings Inc. US4131971040 | 🇺🇸 US | $1,7 Mrd. | B+ |
| 35 | Pharma Mar S.A. ES0169501022 | 🇪🇸 ES | $1,9 Mrd. | B+ |
| 36 | Bavarian Nordic A/S DK0015998017 | 🇩🇰 DK | $2,3 Mrd. | B+ |
| 37 | Galapagos N.V. BE0003818359 | 🇧🇪 BE | $1,7 Mrd. | B+ |
| 38 | BioArctic AB (publ) SE0010323311 | 🇸🇪 SE | $2,9 Mrd. | B+ |
| 39 | Asymchem Laboratories (Tianjin) Co. Ltd. CNE100002BZ6 | 🇨🇳 CN | $5,9 Mrd. | B+ |
| 40 | Innovent Biologics Inc. KYG4818G1010 | 🇨🇳 CN | $18,0 Mrd. | B+ |
| 41 | Rigel Pharmaceuticals Inc. US7665597024 | 🇺🇸 US | $529 Mio. | B+ |
| 42 | Alnylam Pharmaceuticals Inc. US02043Q1076 | 🇺🇸 US | $38,2 Mrd. | B+ |
| 43 | Biocon Limited INE376G01013 | 🇮🇳 IN | $6,0 Mrd. | B |
| 44 | Axsome Therapeutics Inc. US05464T1043 | 🇺🇸 US | $11,7 Mrd. | B |
| 45 | BioMarin Pharmaceutical Inc. US09061G1013 | 🇺🇸 US | $9,6 Mrd. | B |
| 46 | Pharmaron Beijing Co. Ltd. CNE100003PG4 | 🇨🇳 CN | $6,4 Mrd. | B |
| 47 | Celltrion Inc. KR7068270008 | 🇰🇷 KR | $26,2 Mrd. | B |
| 48 | Novo Nordisk A/S DK0062498333 | 🇩🇰 DK | $198,0 Mrd. | B |
| 49 | Gubra A/S DK0062266474 | 🇩🇰 DK | $838 Mio. | B |
| 50 | Xiamen Amoytop Biotech Co. Ltd. CNE100003RT3 | 🇨🇳 CN | $3,5 Mrd. | B |
| 51 | BeOne Medicines Ltd. Class A CNE100005XT6 | 🇨🇭 CH | $36,9 Mrd. | B |
| 52 | Travere Therapeutics Inc. US89422G1076 | 🇺🇸 US | $4,0 Mrd. | B |
| 53 | Ionis Pharmaceuticals Inc. US4622221004 | 🇺🇸 US | $12,0 Mrd. | B |
| 54 | Corcept Therapeutics Incorporated US2183521028 | 🇺🇸 US | $5,9 Mrd. | B |
| 55 | Veracyte Inc. US92337F1075 | 🇺🇸 US | $3,3 Mrd. | B |
| 56 | Shijiazhuang Yiling Pharmaceutical Co. Ltd. CNE1000015S0 | 🇨🇳 CN | $4,0 Mrd. | B |
| 57 | Madrigal Pharmaceuticals Inc. US5588681057 | 🇺🇸 US | $12,0 Mrd. | B |
| 58 | Pharmicell Co. Ltd. KR7005690003 | 🇰🇷 KR | $623 Mio. | C |
| 59 | Beijing Tiantan Biological Products Co. Ltd. CNE000000WF9 | 🇨🇳 CN | $4,0 Mrd. | C |
| 60 | ALTEOGEN Inc. KR7196170005 | 🇰🇷 KR | $12,7 Mrd. | C |
| 61 | Basilea Pharmaceutica AG CH0011432447 | 🇨🇭 CH | $841 Mio. | C |
| 62 | InnoCare Pharma Limited KYG4783B1032 | 🇨🇳 CN | $2,3 Mrd. | C |
| 63 | Shanghai RAAS Blood Products Co. Ltd. CNE100000C31 | 🇨🇳 CN | $5,3 Mrd. | C |
| 64 | Soleno Therapeutics Inc. US8342033094 | 🇺🇸 US | $2,8 Mrd. | C |
| 65 | Zealand Pharma A/S DK0060257814 | 🇩🇰 DK | $3,4 Mrd. | C |
| 66 | CSL Limited AU000000CSL8 | 🇦🇺 AU | $33,2 Mrd. | C |
| 67 | SK Biopharmaceuticals Co. Ltd. KR7326030004 | 🇰🇷 KR | $4,8 Mrd. | C |
| 68 | Hugel Inc. KR7145020004 | 🇰🇷 KR | $1,9 Mrd. | C |
| 69 | Sino Biopharmaceutical Limited KYG8167W1380 | 🇭🇰 HK | $12,2 Mrd. | C |
| 70 | Hualan Biological Engineering Inc. CNE000001JN8 | 🇨🇳 CN | $3,8 Mrd. | C |
| 71 | Jazz Pharmaceuticals plc IE00B4Q5ZN47 | 🇮🇪 IE | $14,4 Mrd. | C |
| 72 | BridgeBio Pharma Inc. US10806X1028 | 🇺🇸 US | $12,8 Mrd. | C |
| 73 | Omeros Corporation US6821431029 | 🇺🇸 US | $847 Mio. | C |
| 74 | MiMedx Group Inc. US6024961012 | 🇺🇸 US | $535 Mio. | C |
| 75 | Haisco Pharmaceutical Group Co. Ltd. CNE100001BC7 | 🇨🇳 CN | $8,4 Mrd. | C |
| 76 | ImmunityBio Inc. US45256X1037 | 🇺🇸 US | $8,4 Mrd. | C |
| 77 | ADMA Biologics Inc. US0008991046 | 🇺🇸 US | $1,9 Mrd. | C |
| 78 | CorMedix Inc. US21900C3088 | 🇺🇸 US | $621 Mio. | C |
| 79 | PharmaResearch Co. Ltd. KR7214450009 | 🇰🇷 KR | $2,1 Mrd. | C |
| 80 | HBM Holdings Limited KYG4403H1002 | 🇨🇳 CN | $1,3 Mrd. | C |
| 81 | RemeGen Co Ltd CNE100005B03 | 🇨🇳 CN | $9,9 Mrd. | C |
| 82 | Puma Biotechnology Inc. US74587V1070 | 🇺🇸 US | $347 Mio. | C |
| 83 | Concord Biotech Limited INE338H01029 | 🇮🇳 IN | $1,2 Mrd. | C |
| 84 | AnaptysBio Inc. US0327241065 | 🇺🇸 US | $2,5 Mrd. | C |
| 85 | Akeso Inc. KYG0146B1032 | 🇨🇳 CN | $13,5 Mrd. | C |
| 86 | Tarsus Pharmaceuticals Inc. US87650L1035 | 🇺🇸 US | $2,7 Mrd. | C |
| 87 | Syngene International Limited INE398R01022 | 🇮🇳 IN | $2,0 Mrd. | C |
| 88 | Onconic Therapeutics KR7476060009 | 🇰🇷 KR | $144 Mio. | C |
| 89 | PTC Therapeutics Inc. US69366J2006 | 🇺🇸 US | $5,8 Mrd. | C |
| 90 | Abeona Therapeutics Inc. US00289Y2063 | 🇺🇸 US | $306 Mio. | C |
| 91 | Genus plc GB0002074580 | 🇬🇧 GB | $2,1 Mrd. | C |
| 92 | Eton Pharmaceuticals Inc. US29772L1089 | 🇺🇸 US | $890 Mio. | C |
| 93 | Abbisko Cayman Limited KYG0028A1085 | 🇨🇳 CN | $864 Mio. | C |
| 94 | Vericel Corporation US92346J1088 | 🇺🇸 US | $1,8 Mrd. | C |
| 95 | RemeGen Co. Ltd. CNE1000048G6 | 🇨🇳 CN | $6,1 Mrd. | D |
| 96 | Mirum Pharmaceuticals Inc. US6047491013 | 🇺🇸 US | $4,8 Mrd. | D |
| 97 | Nanobiotix S.A. FR0011341205 | 🇫🇷 FR | $2,4 Mrd. | D |
| 98 | Moderna Inc. US60770K1079 | 🇺🇸 US | $19,5 Mrd. | D |
| 99 | Praxis Precision Medicines Inc. US74006W2070 | 🇺🇸 US | $6,8 Mrd. | D |
| 100 | Arbutus Biopharma Corporation CA03879J1003 | 🇺🇸 US | $824 Mio. | D |
| 101 | Neuren Pharmaceuticals Limited NZNEUE0001S8 | 🇦🇺 AU | $1,1 Mrd. | D |
| 102 | Theravance Biopharma Inc. KYG8807B1068 | 🇰🇾 KY | $838 Mio. | D |
| 103 | Shanghai Henlius Biotech Inc. CNE100003N76 | 🇨🇳 CN | $4,9 Mrd. | D |
| 104 | UroGen Pharma Ltd. IL0011407140 | 🇺🇸 US | $1,4 Mrd. | D |
| 105 | Shanghai Junshi Biosciences Co. Ltd. CNE1000041Z1 | 🇨🇳 CN | $5,7 Mrd. | D |
| 106 | Onesource Specialty Pharma Ltd. INE013P01021 | 🇮🇳 IN | $2,2 Mrd. | D |
| 107 | Cytokinetics Incorporated US23282W6057 | 🇺🇸 US | $9,4 Mrd. | D |
| 108 | Celcuity Inc. US15102K1007 | 🇺🇸 US | $6,4 Mrd. | D |
| 109 | Telix Pharmaceuticals Limited AU000000TLX2 | 🇦🇺 AU | $3,4 Mrd. | D |
| 110 | Lepu Biopharma Co. Ltd. CNE100004SM4 | 🇨🇳 CN | $1,1 Mrd. | D |
| 111 | Legend Biotech Corporation US52490G1022 | 🇺🇸 US | $5,0 Mrd. | D |
| 112 | Nuvalent Inc. US6707031075 | 🇺🇸 US | $7,3 Mrd. | D |
| 113 | Xeris Biopharma Holdings Inc. US98422E1038 | 🇺🇸 US | $1,0 Mrd. | D |
| 114 | CG Oncology Inc. Common stock US1569441009 | 🇺🇸 US | $5,6 Mrd. | D |
| 115 | Ardelyx Inc. US0396971071 | 🇺🇸 US | $1,5 Mrd. | D |
| 116 | Arcutis Biotherapeutics Inc. US03969K1088 | 🇺🇸 US | $2,5 Mrd. | D |
| 117 | Roivant Sciences Ltd. BMG762791017 | 🇬🇧 GB | $20,4 Mrd. | D |
| 118 | Arcellx Inc. US03940C1009 | 🇺🇸 US | $6,7 Mrd. | D |
| 119 | Syndax Pharmaceuticals Inc. US87164F1057 | 🇺🇸 US | $1,7 Mrd. | D |
| 120 | Niagen Bioscience Inc US1710774076 | 🇺🇸 US | $307 Mio. | D |
| 121 | Vaxcyte Inc. US92243G1085 | 🇺🇸 US | $7,0 Mrd. | D |
| 122 | Iovance Biotherapeutics Inc. US4622601007 | 🇺🇸 US | $1,2 Mrd. | D |
| 123 | Genscript Biotech Corporation KYG3825B1059 | 🇨🇳 CN | $3,8 Mrd. | D |
| 124 | Day One Biopharmaceuticals Inc. US23954D1090 | 🇺🇸 US | $2,2 Mrd. | D |
| 125 | OliX PharmaceuticalsInc KR7226950004 | 🇰🇷 KR | $1,8 Mrd. | D |
| 126 | ArriVent BioPharma Inc. Common Stock US04272N1028 | 🇺🇸 US | $1,3 Mrd. | D |
| 127 | BioCryst Pharmaceuticals Inc. US09058V1035 | 🇺🇸 US | $1,9 Mrd. | D |
| 128 | KalVista Pharmaceuticals Inc. US4834971032 | 🇺🇸 US | $1,4 Mrd. | D |
| 129 | Insmed Incorporated US4576693075 | 🇺🇸 US | $23,2 Mrd. | D |
| 130 | IDEAYA Biosciences Inc. US45166A1025 | 🇺🇸 US | $2,5 Mrd. | D |
| 131 | Bio-Techne Corporation US09073M1045 | 🇺🇸 US | $7,0 Mrd. | D |
| 132 | Kuros Biosciences AG CH0325814116 | 🇨🇭 CH | $1,0 Mrd. | D |
| 133 | CStone Pharmaceuticals KYG2588M1006 | 🇨🇳 CN | $1,6 Mrd. | D |
| 134 | Palvella Therapeutics Inc. US6979471090 | 🇺🇸 US | $1,2 Mrd. | D |
| 135 | Rhythm Pharmaceuticals Inc. US76243J1051 | 🇺🇸 US | $6,0 Mrd. | D |
| 136 | Revolution Medicines Inc. US76155X1000 | 🇺🇸 US | $30,7 Mrd. | D |
| 137 | Arrowhead Pharmaceuticals Inc. US04280A1007 | 🇺🇸 US | $10,4 Mrd. | D |
| 138 | Takara Bio Inc. JP3460200003 | 🇯🇵 JP | $865 Mio. | D |
| 139 | Taysha Gene Therapies Inc. US8776191061 | 🇺🇸 US | $1,4 Mrd. | D |
| 140 | Idorsia Ltd CH0363463438 | 🇨🇭 CH | $1,1 Mrd. | D |
| 141 | XOMA Royalty Corp. US98419J2069 | 🇺🇸 US | $522 Mio. | D |
| 142 | Alumis Inc. Common Stock US0223071020 | 🇺🇸 US | $2,6 Mrd. | D |
| 143 | Kodiak Sciences Inc. US50015M1099 | 🇺🇸 US | $1,9 Mrd. | D |
| 144 | Adaptive Biotechnologies Corporation US00650F1093 | 🇺🇸 US | $2,0 Mrd. | D |
| 145 | Caris Life Sciences Inc. US1421521071 | 🇺🇸 US | $4,1 Mrd. | D |
| 146 | Immunovant Inc. US45258J1025 | 🇺🇸 US | $5,4 Mrd. | D |
| 147 | Pharvaris N.V. NL00150005Y4 | 🇳🇱 NL | $1,9 Mrd. | D |
| 148 | Medy-Tox Inc. KR7086900008 | 🇰🇷 KR | $433 Mio. | D |
| 149 | GNI Group Ltd. JP3386370005 | 🇯🇵 JP | $990 Mio. | D |
| 150 | Novavax Inc. US6700024010 | 🇺🇸 US | $1,5 Mrd. | D |
| 151 | Beam Therapeutics Inc. US07373V1052 | 🇺🇸 US | $2,8 Mrd. | D |
| 152 | Esperion Therapeutics Inc. US29664W1053 | 🇺🇸 US | $651 Mio. | D |
| 153 | MeiraGTx Holdings plc KYG596651029 | 🇺🇸 US | $871 Mio. | D |
| 154 | Fortrea Holdings Inc. US34965K1079 | 🇺🇸 US | $1,3 Mrd. | D |
| 155 | Trevi Therapeutics Inc. US89532M1018 | 🇺🇸 US | $1,9 Mrd. | D |
| 156 | Alpha Tau Medical Ltd. IL0011839383 | 🇮🇱 IL | $883 Mio. | D |
| 157 | Protalix BioTherapeutics Inc. US74365A3095 | 🇺🇸 US | $154 Mio. | D |
| 158 | Stoke Therapeutics Inc. US86150R1077 | 🇺🇸 US | $1,8 Mrd. | D |
| 159 | Terns Pharmaceuticals Inc. US8808811074 | 🇺🇸 US | $4,8 Mrd. | D |
| 160 | LigaChem Biosciences Inc. KR7141080002 | 🇰🇷 KR | $3,5 Mrd. | D |
| 161 | CARsgen Therapeutics Holdings Limited KYG1996C1006 | 🇨🇳 CN | $1,3 Mrd. | D |
| 162 | BioAge Labs Inc. US09077V1008 | 🇺🇸 US | $578 Mio. | D |
| 163 | CRISPR Therapeutics AG CH0334081137 | 🇨🇭 CH | $4,7 Mrd. | D |
| 164 | Spyre Therapeutics Inc. US00773J2024 | 🇺🇸 US | $4,2 Mrd. | D |
| 165 | Ultragenyx Pharmaceutical Inc. US90400D1081 | 🇺🇸 US | $2,4 Mrd. | D |
| 166 | Phathom Pharmaceuticals Inc. US71722W1071 | 🇺🇸 US | $908 Mio. | D |
| 167 | Vera Therapeutics Inc. US92337R1014 | 🇺🇸 US | $2,5 Mrd. | D |
| 168 | Cogent Biosciences Inc. US19240Q2012 | 🇺🇸 US | $5,4 Mrd. | D |
| 169 | Financière de Tubize S.A. BE0003823409 | 🇧🇪 BE | $10,2 Mrd. | D |
| 170 | Dianthus Therapeutics Inc. US2528281080 | 🇺🇸 US | $3,5 Mrd. | D |
| 171 | Definium Therapeutics Inc. CA24477V1058 | 🇺🇸 US | $2,2 Mrd. | D |
| 172 | NewAmsterdam Pharma Company N.V. NL00150012L7 | 🇳🇱 NL | $4,0 Mrd. | D |
| 173 | Nkarta Inc. US65487U1088 | 🇺🇸 US | $192 Mio. | D |
| 174 | Abivax S.A. FR0012333284 | 🇫🇷 FR | $8,8 Mrd. | D |
| 175 | Arcus Biosciences Inc. US03969F1093 | 🇺🇸 US | $2,4 Mrd. | D |
| 176 | Centessa Pharmaceuticals plc US1523091007 | 🇬🇧 GB | $6,1 Mrd. | D |
| 177 | Annexon Inc. US03589W1027 | 🇺🇸 US | $593 Mio. | D |
| 178 | Sarepta Therapeutics Inc. US8036071004 | 🇺🇸 US | $1,8 Mrd. | D |
| 179 | Tyra Biosciences Inc. US90240B1061 | 🇺🇸 US | $2,1 Mrd. | D |
| 180 | Zai Lab Limited KYG9887T1168 | 🇨🇳 CN | $2,1 Mrd. | D |
| 181 | Kura Oncology Inc. US50127T1097 | 🇺🇸 US | $817 Mio. | D |
| 182 | Pharming Group N.V. NL0010391025 | 🇳🇱 NL | $893 Mio. | D |
| 183 | Protagonist Therapeutics Inc. US74366E1029 | 🇺🇸 US | $6,5 Mrd. | D |
| 184 | Kymera Therapeutics Inc. US5015751044 | 🇺🇸 US | $6,6 Mrd. | D |
| 185 | Edgewise Therapeutics Inc. US28036F1057 | 🇺🇸 US | $3,4 Mrd. | D |
| 186 | Emergent BioSolutions Inc. US29089Q1058 | 🇺🇸 US | $419 Mio. | D |
| 187 | Scholar Rock Holding Corporation US80706P1030 | 🇺🇸 US | $5,7 Mrd. | D |
| 188 | Crinetics Pharmaceuticals Inc. US22663K1079 | 🇺🇸 US | $3,7 Mrd. | D |
| 189 | Intellia Therapeutics Inc. US45826J1051 | 🇺🇸 US | $1,4 Mrd. | D |
| 190 | Immunome Inc. US45257U1088 | 🇺🇸 US | $1,9 Mrd. | D |
| 191 | Apogee Therapeutics Inc. US03770N1019 | 🇺🇸 US | $4,9 Mrd. | D |
| 192 | Peptron Inc. KR7087010005 | 🇰🇷 KR | $3,6 Mrd. | D |
| 193 | Inhibrx Biosciences Inc. US45720N1037 | 🇺🇸 US | $1,6 Mrd. | D |
| 194 | Ocumension Therapeutics KYG674111011 | 🇨🇳 CN | $650 Mio. | D |
| 195 | Geron Corporation US3741631036 | 🇺🇸 US | $789 Mio. | D |
| 196 | Dyne Therapeutics Inc. US26818M1080 | 🇺🇸 US | $2,7 Mrd. | D |
| 197 | Nurix Therapeutics Inc. US67080M1036 | 🇺🇸 US | $1,3 Mrd. | D |
| 198 | Oxford Nanopore Technologies plc GB00BP6S8Z30 | 🇬🇧 GB | $1,6 Mrd. | D |
| 199 | NRx Pharmaceuticals Inc. US6294442099 | 🇺🇸 US | $54 Mio. | D |
| 200 | Oxford Biomedica plc GB00BDFBVT43 | 🇬🇧 GB | $988 Mio. | D |
| 201 | Ocular Therapeutix Inc. US67576A1007 | 🇺🇸 US | $1,8 Mrd. | D |
| 202 | Monopar Therapeutics Inc. US61023L2079 | 🇺🇸 US | $377 Mio. | D |
| 203 | BioNTech SE US09075V1026 | 🇩🇪 DE | $22,5 Mrd. | D |
| 204 | Allogene Therapeutics Inc. US0197701065 | 🇺🇸 US | $473 Mio. | D |
| 205 | Monte Rosa Therapeutics Inc. US61225M1027 | 🇺🇸 US | $1,2 Mrd. | D |
| 206 | Xenon Pharmaceuticals Inc. CA98420N1050 | 🇨🇦 CA | $4,2 Mrd. | D |
| 207 | Zymeworks Inc. US98985Y1082 | 🇨🇦 CA | $1,8 Mrd. | D |
| 208 | Disc Medicine Inc. US2546041011 | 🇺🇸 US | $2,6 Mrd. | D |
| 209 | Precigen Inc. US74017N1054 | 🇺🇸 US | $1,2 Mrd. | D |
| 210 | Mesoblast Limited AU000000MSB8 | 🇦🇺 AU | $1,9 Mrd. | D |
| 211 | Relay Therapeutics Inc. US75943R1023 | 🇺🇸 US | $2,3 Mrd. | D |
| 212 | Ascentage Pharma Group International KYG0519B1023 | 🇨🇳 CN | $1,8 Mrd. | D |
| 213 | Larimar Therapeutics Inc. US5171251003 | 🇺🇸 US | $277 Mio. | D |
| 214 | Tango Therapeutics Inc. US87583X1090 | 🇺🇸 US | $2,4 Mrd. | D |
| 215 | Relmada Therapeutics Inc. US75955J4022 | 🇺🇸 US | $465 Mio. | D |
| 216 | Achieve Life Sciences Inc. US0044685008 | 🇨🇦 CA | $255 Mio. | D |
| 217 | ADC Therapeutics S.A. CH0499880968 | 🇨🇭 CH | $403 Mio. | D |
| 218 | Alector Inc. US0144421072 | 🇺🇸 US | $235 Mio. | D |
| 219 | Erasca Inc. US29479A1088 | 🇺🇸 US | $3,2 Mrd. | D |
| 220 | 4D Molecular Therapeutics Inc. US35104E1001 | 🇺🇸 US | $437 Mio. | D |
| 221 | Agios Pharmaceuticals Inc. US00847X1046 | 🇺🇸 US | $1,7 Mrd. | D |
| 222 | Oruka Therapeutics Inc. US6876041087 | 🇺🇸 US | $2,2 Mrd. | D |
| 223 | Green Cross Holdings Corporation KR7005250006 | 🇰🇷 KR | $433 Mio. | D |
| 224 | Celldex Therapeutics Inc. US15117B2025 | 🇺🇸 US | $2,0 Mrd. | D |
| 225 | DBV Technologies S.A. US23306J3095 | 🇫🇷 FR | $449 Mio. | D |
| 226 | Codexis Inc. US1920051067 | 🇺🇸 US | $232 Mio. | D |
| 227 | MannKind Corporation US56400P7069 | 🇺🇸 US | $924 Mio. | D |
| 228 | Immunocore Holdings plc US45258D1054 | 🇬🇧 GB | $1,4 Mrd. | D |
| 229 | Immatics N.V. NL0015285941 | 🇩🇪 DE | $1,4 Mrd. | D |
| 230 | SELLAS Life Sciences Group Inc. US81642T2096 | 🇺🇸 US | $1,0 Mrd. | D |
| 231 | Everest Medicines Limited KYG3224E1061 | 🇨🇳 CN | $1,4 Mrd. | D |
| 232 | Kyverna Therapeutics Inc. US5019761049 | 🇺🇸 US | $374 Mio. | D |
| 233 | Oculis Holding AG CH1242303498 | 🇨🇭 CH | $1,6 Mrd. | D |
| 234 | Enliven Therapeutics Inc. US29337E1029 | 🇺🇸 US | $2,4 Mrd. | D |
| 235 | Sionna Therapeutics Inc. US8294011080 | 🇺🇸 US | $1,8 Mrd. | D |
| 236 | Voronoi Inc. KR7310210000 | 🇷🇴 RO | $2,8 Mrd. | D |
| 237 | Keymed Biosciences Inc. KYG5252B1023 | 🇨🇳 CN | $2,4 Mrd. | D |
| 238 | Viridian Therapeutics Inc. US92790C1045 | 🇺🇸 US | $1,4 Mrd. | D |
| 239 | Solid Biosciences Inc. US83422E2046 | 🇺🇸 US | $507 Mio. | D |
| 240 | Vanda Pharmaceuticals Inc. US9216591084 | 🇺🇸 US | $366 Mio. | D |
| 241 | SK bioscience Co.Ltd. KR7302440003 | 🇰🇷 KR | $2,1 Mrd. | D |
| 242 | EyePoint Pharmaceuticals Inc. US30233G2093 | 🇺🇸 US | $981 Mio. | D |
| 243 | OmniAb Inc. US68218J1034 | 🇺🇸 US | $273 Mio. | D |
| 244 | Corvus Pharmaceuticals Inc. US2210151005 | 🇺🇸 US | $1,0 Mrd. | D |
| 245 | Mineralys Therapeutics Inc. US6031701013 | 🇺🇸 US | $1,7 Mrd. | D |
| 246 | Vir Biotechnology Inc. US92764N1028 | 🇺🇸 US | $1,5 Mrd. | D |
| 247 | Xencor Inc. US98401F1057 | 🇺🇸 US | $820 Mio. | D |
| 248 | Nektar Therapeutics US6402683063 | 🇺🇸 US | $1,3 Mrd. | D |
| 249 | Nuvation Bio Inc. US67080N1019 | 🇺🇸 US | $1,5 Mrd. | D |
| 250 | Bicara Therapeutics Inc. Common Stock US0554771032 | 🇺🇸 US | $1,1 Mrd. | D |
| 251 | Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. CNE100004090 | 🇨🇳 CN | $7,4 Mrd. | D |
| 252 | D&D Pharmatech KR7347850000 | 🇰🇷 KR | $1,7 Mrd. | D |
| 253 | HLB Co. Ltd. KR7028300002 | 🇰🇷 KR | $4,2 Mrd. | D |
| 254 | SanBio Company Limited JP3336750009 | 🇯🇵 JP | $824 Mio. | D |
| 255 | Tectonic Therapeutic Inc. US8789721086 | 🇺🇸 US | $523 Mio. | D |
| 256 | Absci Corporation US00091E1091 | 🇺🇸 US | $771 Mio. | D |
| 257 | Foghorn Therapeutics Inc. US3441741077 | 🇺🇸 US | $224 Mio. | D |
| 258 | Septerna Inc. US81734D1046 | 🇺🇸 US | $1,2 Mrd. | D |
| 259 | Denali Therapeutics Inc. US24823R1059 | 🇺🇸 US | $2,9 Mrd. | D |
| 260 | Nxera Pharma Co. Ltd. JP3431300007 | 🇯🇵 JP | $662 Mio. | D |
| 261 | Maravai LifeSciences Holdings Inc. US56600D1072 | 🇺🇸 US | $1,1 Mrd. | D |
| 262 | GH Research PLC IE000GID8VI0 | 🇮🇪 IE | $1,5 Mrd. | D |
| 263 | Jade Biosciences Inc. US0080642061 | 🇺🇸 US | $718 Mio. | D |
| 264 | Savara Inc. US8051111016 | 🇺🇸 US | $1,0 Mrd. | D |
| 265 | Amylyx Pharmaceuticals Inc. US03237H1014 | 🇺🇸 US | $1,1 Mrd. | D |
| 266 | Rapport Therapeutics Inc. Common Stock US75383L1026 | 🇺🇸 US | $1,3 Mrd. | D |
| 267 | Capricor Therapeutics Inc. US14070B3096 | 🇺🇸 US | $1,3 Mrd. | D |
| 268 | Design Therapeutics Inc. US25056L1035 | 🇺🇸 US | $668 Mio. | D |
| 269 | Alphamab Oncology KYG0330A1013 | 🇨🇳 CN | $1,1 Mrd. | D |
| 270 | Alto Neuroscience Inc. US02157Q1094 | 🇺🇸 US | $765 Mio. | D |
| 271 | Ascletis Pharma Inc. KYG0520K1094 | 🇨🇳 CN | $2,1 Mrd. | D |
| 272 | Heron Therapeutics Inc. US4277461020 | 🇺🇸 US | $136 Mio. | D |
| 273 | Hebei Changshan Biochemical Pharmaceutical Co. Ltd. CNE1000016C2 | 🇨🇳 CN | $5,7 Mrd. | D |
| 274 | Chabiotech Co.Ltd. KR7085660009 | 🇰🇷 KR | $699 Mio. | D |
| 275 | LeonaBio Inc. US04746L2034 | 🇺🇸 US | $40 Mio. | D |
| 276 | uniQure N.V. NL0010696654 | 🇳🇱 NL | $1,7 Mrd. | D |
| 277 | AbCellera Biologics Inc. CA00288U1066 | 🇨🇦 CA | $1,3 Mrd. | D |
| 278 | Aura Biosciences Inc. US05153U1079 | 🇺🇸 US | $480 Mio. | D |
| 279 | Viking Therapeutics Inc. US92686J1060 | 🇺🇸 US | $3,3 Mrd. | D |
| 280 | ARS Pharmaceuticals Inc. US82835W1080 | 🇺🇸 US | $725 Mio. | D |
| 281 | Anavex Life Sciences Corp. US0327973006 | 🇺🇸 US | $267 Mio. | D |
| 282 | Summit Therapeutics Inc. US86627T1088 | 🇺🇸 US | $12,4 Mrd. | D |
| 283 | Keros Therapeutics Inc. US4923271013 | 🇺🇸 US | $325 Mio. | D |
| 284 | BINEX Co. Ltd. KR7053030003 | 🇰🇷 KR | $200 Mio. | D |
| 285 | Prothena Corporation plc IE00B91XRN20 | 🇮🇪 IE | $502 Mio. | D |
| 286 | Bright Minds Biosciences Inc. CA10919W4056 | 🇨🇦 CA | $657 Mio. | D |
| 287 | Editas Medicine Inc. US28106W1036 | 🇺🇸 US | $248 Mio. | D |
| 288 | Chongqing Zhifei Biological Products Co. Ltd. CNE100000V20 | 🇨🇳 CN | $5,3 Mrd. | D |
| 289 | Eledon Pharmaceuticals Inc. US28617K1016 | 🇺🇸 US | $215 Mio. | D |
| 290 | Caribou Biosciences Inc. US1420381089 | 🇺🇸 US | $221 Mio. | D |
| 291 | Tonix Pharmaceuticals Holding Corp. US8902608392 | 🇺🇸 US | $227 Mio. | D |
| 292 | Aclaris Therapeutics Inc. US00461U1051 | 🇺🇸 US | $531 Mio. | D |
| 293 | Atea Pharmaceuticals Inc. US04683R1068 | 🇺🇸 US | $331 Mio. | D |
| 294 | Arcturus Therapeutics Holdings Inc. US03969T1097 | 🇺🇸 US | $200 Mio. | D |
| 295 | Gossamer Bio Inc. US38341P1021 | 🇺🇸 US | $45 Mio. | D |
| 296 | Greenwich LifeSciences Inc. US3968791083 | 🇺🇸 US | $377 Mio. | D |
| 297 | Recursion Pharmaceuticals Inc. US75629V1044 | 🇺🇸 US | $1,3 Mrd. | D |
| 298 | MBX Biosciences Inc. Common Stock US55287L1017 | 🇺🇸 US | $1,0 Mrd. | D |
| 299 | MediWound Ltd. IL0011316309 | 🇮🇱 IL | $178 Mio. | D |
| 300 | Coherus Oncology Inc. US19249H1032 | 🇺🇸 US | $182 Mio. | D |
| 301 | Enanta Pharmaceuticals Inc. US29251M1062 | 🇺🇸 US | $312 Mio. | D |
| 302 | Zenas BioPharma Inc. US98937L1052 | 🇺🇸 US | $755 Mio. | D |
| 303 | Candel Therapeutics Inc. US1374041093 | 🇺🇸 US | $481 Mio. | D |
| 304 | Olema Pharmaceuticals Inc. US68062P1066 | 🇺🇸 US | $1,1 Mrd. | D |
| 305 | Duality Biotherapeutics Inc. KYG2929M1087 | 🇨🇳 CN | $2,5 Mrd. | D |
| 306 | Structure Therapeutics Inc. US86366E1064 | 🇺🇸 US | $2,1 Mrd. | D |
| 307 | TaiMed Biologics Inc. TW0004147004 | 🇹🇼 TW | $429 Mio. | D |
| 308 | Arvinas Inc. US04335A1051 | 🇺🇸 US | $566 Mio. | D |
| 309 | Neurogene Inc. US64135M1053 | 🇺🇸 US | $442 Mio. | D |
| 310 | Akebia Therapeutics Inc. US00972D1054 | 🇺🇸 US | $271 Mio. | D |
| 311 | Fate Therapeutics Inc. US31189P1021 | 🇺🇸 US | $202 Mio. | D |
| 312 | EirGenix Inc. TW0006589005 | 🇹🇼 TW | $419 Mio. | D |
| 313 | Maze Therapeutics Inc. US5787841007 | 🇺🇸 US | $1,4 Mrd. | D |
| 314 | Oneness Biotech Co. Ltd. TW0004743000 | 🇹🇼 TW | $770 Mio. | D |
| 315 | Upstream Bio Inc. US91678A1079 | 🇺🇸 US | $463 Mio. | D |
| 316 | OPKO Health Inc. US68375N1037 | 🇺🇸 US | $853 Mio. | D |
| 317 | ORIC Pharmaceuticals Inc. US68622P1093 | 🇺🇸 US | $821 Mio. | D |
| 318 | Protara Therapeutics Inc. US74365U1079 | 🇺🇸 US | $178 Mio. | D |
| 319 | Ginkgo Bioworks Holdings Inc. US37611X2099 | 🇺🇸 US | $481 Mio. | D |
| 320 | Clarity Pharmaceuticals Ltd AU0000165375 | 🇦🇺 AU | $710 Mio. | D |
| 321 | Milestone Pharmaceuticals Inc. CA59935V1076 | 🇨🇦 CA | $125 Mio. | D |
| 322 | Humacyte Inc. US44486Q1031 | 🇺🇸 US | $151 Mio. | D |
| 323 | Sana Biotechnology Inc. US7995661045 | 🇺🇸 US | $846 Mio. | D |
| 324 | Quantum-Si incorporated US74765K1051 | 🇺🇸 US | $169 Mio. | D |
| 325 | Voyager Therapeutics Inc. US92915B1061 | 🇺🇸 US | $213 Mio. | D |
| 326 | CytomX Therapeutics Inc. US23284F1057 | 🇺🇸 US | $563 Mio. | D |
| 327 | LENZ Therapeutics Inc. US52635N1037 | 🇺🇸 US | $216 Mio. | D |
| 328 | Aardvark Therapeutics Inc. Common Stock US0029421007 | 🇺🇸 US | $95 Mio. | D |
| 329 | Biohaven Ltd. VGG1110E1079 | 🇺🇸 US | $899 Mio. | D |
| 330 | Rezolute Inc. US76200L3096 | 🇺🇸 US | $312 Mio. | D |
| 331 | PeptiDream Inc. JP3836750004 | 🇯🇵 JP | $930 Mio. | D |
| 332 | Prime Medicine Inc. US74168J1016 | 🇺🇸 US | $508 Mio. | D |
| 333 | Lexeo Therapeutics Inc. Common Stock US52886X1072 | 🇺🇸 US | $370 Mio. | D |
| 334 | Wave Life Sciences Ltd. SG9999014716 | 🇸🇬 SG | $1,2 Mrd. | D |
| 335 | Aldeyra Therapeutics Inc. US01438T1060 | 🇺🇸 US | $97 Mio. | D |
| 336 | MoonLake Immunotherapeutics KY61559X1045 | 🇨🇭 CH | $1,2 Mrd. | D |
| 337 | Entrada Therapeutics Inc. US29384C1080 | 🇺🇸 US | $229 Mio. | D |
| 338 | Compass Therapeutics Inc. US20454B1044 | 🇺🇸 US | $253 Mio. | D |
| 339 | GI Innovation Inc. KR7358570000 | 🇰🇷 KR | $435 Mio. | D |
| 340 | Vor Biopharma Inc. US9290332074 | 🇺🇸 US | $115 Mio. | D |
| 341 | Rocket Pharmaceuticals Inc. US77313F1066 | 🇺🇸 US | $335 Mio. | D |
| 342 | Inhibikase Therapeutics Inc. US45719W2052 | 🇺🇸 US | $123 Mio. | D |
| 343 | Fulcrum Therapeutics Inc. US3596161097 | 🇺🇸 US | $330 Mio. | D |
| 344 | Verastem Inc. US92337C2035 | 🇺🇸 US | $295 Mio. | D |
| 345 | Janux Therapeutics Inc. US47103J1051 | 🇺🇸 US | $856 Mio. | D |
| 346 | REGENXBIO Inc. US75901B1070 | 🇺🇸 US | $292 Mio. | D |
| 347 | Pasithea Therapeutics Corp. US70261F2020 | 🇺🇸 US | $5 Mio. | D |
| 348 | Altimmune Inc. US02155H2004 | 🇺🇸 US | $247 Mio. | D |
| 349 | Polaris Group KYG7171A1085 | 🇺🇸 US | $484 Mio. | D |
| 350 | Benitec Biopharma Inc. US08205P2092 | 🇺🇸 US | $286 Mio. | D |
| 351 | Replimune Group Inc. US76029N1063 | 🇺🇸 US | $414 Mio. | D |
| 1 | Novo Nordisk A/S DK0062498333 | 🇩🇰 DK | $198,0 Mrd. | B |
| 2 | Vertex Pharmaceuticals Incorporated US92532F1003 | 🇺🇸 US | $110,8 Mrd. | A |
| 3 | Regeneron Pharmaceuticals Inc. US75886F1075 | 🇺🇸 US | $64,9 Mrd. | A+ |
| 4 | UCB S.A. BE0003739530 | 🇧🇪 BE | $51,0 Mrd. | A+ |
| 5 | argenx SE NL0010832176 | 🇳🇱 NL | $48,7 Mrd. | A |
| 6 | Samsung Biologics Co.Ltd. KR7207940008 | 🇰🇷 KR | $41,7 Mrd. | B+ |
| 7 | Alnylam Pharmaceuticals Inc. US02043Q1076 | 🇺🇸 US | $38,2 Mrd. | B+ |
| 8 | BeOne Medicines Ltd. Class A CNE100005XT6 | 🇨🇭 CH | $36,9 Mrd. | B |
| 9 | CSL Limited AU000000CSL8 | 🇦🇺 AU | $33,2 Mrd. | C |
| 10 | BeOne Medicines AG CH1391448177 | 🇨🇭 CH | $30,8 Mrd. | B+ |
| 11 | Revolution Medicines Inc. US76155X1000 | 🇺🇸 US | $30,7 Mrd. | D |
| 12 | Celltrion Inc. KR7068270008 | 🇰🇷 KR | $26,2 Mrd. | B |
| 13 | United Therapeutics Corporation US91307C1027 | 🇺🇸 US | $24,1 Mrd. | A+ |
| 14 | Insmed Incorporated US4576693075 | 🇺🇸 US | $23,2 Mrd. | D |
| 15 | BioNTech SE US09075V1026 | 🇩🇪 DE | $22,5 Mrd. | D |
| 16 | Royalty Pharma plc GB00BMVP7Y09 | 🇺🇸 US | $22,4 Mrd. | A+ |
| 17 | Roivant Sciences Ltd. BMG762791017 | 🇬🇧 GB | $20,4 Mrd. | D |
| 18 | Moderna Inc. US60770K1079 | 🇺🇸 US | $19,5 Mrd. | D |
| 19 | Incyte Corporation US45337C1027 | 🇺🇸 US | $19,0 Mrd. | A+ |
| 20 | Innovent Biologics Inc. KYG4818G1010 | 🇨🇳 CN | $18,0 Mrd. | B+ |
| 21 | WuXi Biologics (Cayman) Inc. KYG970081173 | 🇨🇳 CN | $17,6 Mrd. | A |
| 22 | Genmab A/S US3723032062 | 🇩🇰 DK | $16,2 Mrd. | A |
| 23 | Neurocrine Biosciences Inc. US64125C1099 | 🇺🇸 US | $15,8 Mrd. | A+ |
| 24 | Ascendis Pharma A/S DK0060615755 | 🇩🇰 DK | $14,7 Mrd. | A |
| 25 | Jazz Pharmaceuticals plc IE00B4Q5ZN47 | 🇮🇪 IE | $14,4 Mrd. | C |
| 26 | Akeso Inc. KYG0146B1032 | 🇨🇳 CN | $13,5 Mrd. | C |
| 27 | BridgeBio Pharma Inc. US10806X1028 | 🇺🇸 US | $12,8 Mrd. | C |
| 28 | ALTEOGEN Inc. KR7196170005 | 🇰🇷 KR | $12,7 Mrd. | C |
| 29 | Exelixis Inc. US30161Q1040 | 🇺🇸 US | $12,5 Mrd. | A+ |
| 30 | Summit Therapeutics Inc. US86627T1088 | 🇺🇸 US | $12,4 Mrd. | D |
| 31 | Sino Biopharmaceutical Limited KYG8167W1380 | 🇭🇰 HK | $12,2 Mrd. | C |
| 32 | Madrigal Pharmaceuticals Inc. US5588681057 | 🇺🇸 US | $12,0 Mrd. | B |
| 33 | Ionis Pharmaceuticals Inc. US4622221004 | 🇺🇸 US | $12,0 Mrd. | B |
| 34 | Axsome Therapeutics Inc. US05464T1043 | 🇺🇸 US | $11,7 Mrd. | B |
| 35 | Arrowhead Pharmaceuticals Inc. US04280A1007 | 🇺🇸 US | $10,4 Mrd. | D |
| 36 | Financière de Tubize S.A. BE0003823409 | 🇧🇪 BE | $10,2 Mrd. | D |
| 37 | RemeGen Co Ltd CNE100005B03 | 🇨🇳 CN | $9,9 Mrd. | C |
| 38 | BioMarin Pharmaceutical Inc. US09061G1013 | 🇺🇸 US | $9,6 Mrd. | B |
| 39 | Cytokinetics Incorporated US23282W6057 | 🇺🇸 US | $9,4 Mrd. | D |
| 40 | Abivax S.A. FR0012333284 | 🇫🇷 FR | $8,8 Mrd. | D |
| 41 | ALK-Abelló A/S DK0061802139 | 🇩🇰 DK | $8,6 Mrd. | A+ |
| 42 | Krystal Biotech Inc. US5011471027 | 🇺🇸 US | $8,6 Mrd. | A |
| 43 | Haisco Pharmaceutical Group Co. Ltd. CNE100001BC7 | 🇨🇳 CN | $8,4 Mrd. | C |
| 44 | ImmunityBio Inc. US45256X1037 | 🇺🇸 US | $8,4 Mrd. | C |
| 45 | Halozyme Therapeutics Inc. US40637H1095 | 🇺🇸 US | $8,0 Mrd. | A |
| 46 | Sunshine Guojian Pharmaceutical (Shanghai) Co. Ltd CNE1000062X2 | 🇨🇳 CN | $7,8 Mrd. | A |
| 47 | Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. CNE100004090 | 🇨🇳 CN | $7,4 Mrd. | D |
| 48 | Nuvalent Inc. US6707031075 | 🇺🇸 US | $7,3 Mrd. | D |
| 49 | Vaxcyte Inc. US92243G1085 | 🇺🇸 US | $7,0 Mrd. | D |
| 50 | Bio-Techne Corporation US09073M1045 | 🇺🇸 US | $7,0 Mrd. | D |
| 51 | Praxis Precision Medicines Inc. US74006W2070 | 🇺🇸 US | $6,8 Mrd. | D |
| 52 | Arcellx Inc. US03940C1009 | 🇺🇸 US | $6,7 Mrd. | D |
| 53 | Kymera Therapeutics Inc. US5015751044 | 🇺🇸 US | $6,6 Mrd. | D |
| 54 | Protagonist Therapeutics Inc. US74366E1029 | 🇺🇸 US | $6,5 Mrd. | D |
| 55 | Celcuity Inc. US15102K1007 | 🇺🇸 US | $6,4 Mrd. | D |
| 56 | Pharmaron Beijing Co. Ltd. CNE100003PG4 | 🇨🇳 CN | $6,4 Mrd. | B |
| 57 | 3SBio Inc. KYG8875G1029 | 🇨🇳 CN | $6,3 Mrd. | A |
| 58 | Alkermes plc IE00B56GVS15 | 🇮🇪 IE | $6,2 Mrd. | B+ |
| 59 | RemeGen Co. Ltd. CNE1000048G6 | 🇨🇳 CN | $6,1 Mrd. | D |
| 60 | Centessa Pharmaceuticals plc US1523091007 | 🇬🇧 GB | $6,1 Mrd. | D |
| 61 | TG Therapeutics Inc. US88322Q1085 | 🇺🇸 US | $6,0 Mrd. | A |
| 62 | Biocon Limited INE376G01013 | 🇮🇳 IN | $6,0 Mrd. | B |
| 63 | Shanghai Allist Pharmaceuticals Co. Ltd. CNE100005XJ7 | 🇨🇳 CN | $6,0 Mrd. | B+ |
| 64 | Rhythm Pharmaceuticals Inc. US76243J1051 | 🇺🇸 US | $6,0 Mrd. | D |
| 65 | Asymchem Laboratories (Tianjin) Co. Ltd. CNE100002BZ6 | 🇨🇳 CN | $5,9 Mrd. | B+ |
| 66 | Corcept Therapeutics Incorporated US2183521028 | 🇺🇸 US | $5,9 Mrd. | B |
| 67 | PTC Therapeutics Inc. US69366J2006 | 🇺🇸 US | $5,8 Mrd. | C |
| 68 | Shanghai Junshi Biosciences Co. Ltd. CNE1000041Z1 | 🇨🇳 CN | $5,7 Mrd. | D |
| 69 | Scholar Rock Holding Corporation US80706P1030 | 🇺🇸 US | $5,7 Mrd. | D |
| 70 | Hebei Changshan Biochemical Pharmaceutical Co. Ltd. CNE1000016C2 | 🇨🇳 CN | $5,7 Mrd. | D |
| 71 | CG Oncology Inc. Common stock US1569441009 | 🇺🇸 US | $5,6 Mrd. | D |
| 72 | Immunovant Inc. US45258J1025 | 🇺🇸 US | $5,4 Mrd. | D |
| 73 | Cogent Biosciences Inc. US19240Q2012 | 🇺🇸 US | $5,4 Mrd. | D |
| 74 | Shanghai RAAS Blood Products Co. Ltd. CNE100000C31 | 🇨🇳 CN | $5,3 Mrd. | C |
| 75 | Chongqing Zhifei Biological Products Co. Ltd. CNE100000V20 | 🇨🇳 CN | $5,3 Mrd. | D |
| 76 | Apellis Pharmaceuticals Inc. US03753U1060 | 🇺🇸 US | $5,3 Mrd. | A |
| 77 | Liquidia Corporation US53635D2027 | 🇺🇸 US | $5,1 Mrd. | B+ |
| 78 | Legend Biotech Corporation US52490G1022 | 🇺🇸 US | $5,0 Mrd. | D |
| 79 | Apogee Therapeutics Inc. US03770N1019 | 🇺🇸 US | $4,9 Mrd. | D |
| 80 | Shanghai Henlius Biotech Inc. CNE100003N76 | 🇨🇳 CN | $4,9 Mrd. | D |
| 81 | SK Biopharmaceuticals Co. Ltd. KR7326030004 | 🇰🇷 KR | $4,8 Mrd. | C |
| 82 | Mirum Pharmaceuticals Inc. US6047491013 | 🇺🇸 US | $4,8 Mrd. | D |
| 83 | Terns Pharmaceuticals Inc. US8808811074 | 🇺🇸 US | $4,8 Mrd. | D |
| 84 | CRISPR Therapeutics AG CH0334081137 | 🇨🇭 CH | $4,7 Mrd. | D |
| 85 | Amicus Therapeutics Inc. US03152W1099 | 🇺🇸 US | $4,5 Mrd. | A |
| 86 | Xenon Pharmaceuticals Inc. CA98420N1050 | 🇨🇦 CA | $4,2 Mrd. | D |
| 87 | Spyre Therapeutics Inc. US00773J2024 | 🇺🇸 US | $4,2 Mrd. | D |
| 88 | HLB Co. Ltd. KR7028300002 | 🇰🇷 KR | $4,2 Mrd. | D |
| 89 | Ligand Pharmaceuticals Incorporated US53220K5048 | 🇺🇸 US | $4,2 Mrd. | A+ |
| 90 | Caris Life Sciences Inc. US1421521071 | 🇺🇸 US | $4,1 Mrd. | D |
| 91 | Shijiazhuang Yiling Pharmaceutical Co. Ltd. CNE1000015S0 | 🇨🇳 CN | $4,0 Mrd. | B |
| 92 | Kiniksa Pharmaceuticals Ltd. GB00BRXB0C07 | 🇧🇲 BM | $4,0 Mrd. | B+ |
| 93 | NewAmsterdam Pharma Company N.V. NL00150012L7 | 🇳🇱 NL | $4,0 Mrd. | D |
| 94 | Travere Therapeutics Inc. US89422G1076 | 🇺🇸 US | $4,0 Mrd. | B |
| 95 | Beijing Tiantan Biological Products Co. Ltd. CNE000000WF9 | 🇨🇳 CN | $4,0 Mrd. | C |
| 96 | Catalyst Pharmaceuticals Inc. US14888U1016 | 🇺🇸 US | $3,8 Mrd. | A+ |
| 97 | Hualan Biological Engineering Inc. CNE000001JN8 | 🇨🇳 CN | $3,8 Mrd. | C |
| 98 | Genscript Biotech Corporation KYG3825B1059 | 🇨🇳 CN | $3,8 Mrd. | D |
| 99 | Simcere Pharmaceutical Group Limited HK0000658531 | 🇨🇳 CN | $3,7 Mrd. | B+ |
| 100 | Crinetics Pharmaceuticals Inc. US22663K1079 | 🇺🇸 US | $3,7 Mrd. | D |
| 101 | Peptron Inc. KR7087010005 | 🇰🇷 KR | $3,6 Mrd. | D |
| 102 | ACADIA Pharmaceuticals Inc. US0042251084 | 🇺🇸 US | $3,5 Mrd. | B+ |
| 103 | Dianthus Therapeutics Inc. US2528281080 | 🇺🇸 US | $3,5 Mrd. | D |
| 104 | LigaChem Biosciences Inc. KR7141080002 | 🇰🇷 KR | $3,5 Mrd. | D |
| 105 | Xiamen Amoytop Biotech Co. Ltd. CNE100003RT3 | 🇨🇳 CN | $3,5 Mrd. | B |
| 106 | Zealand Pharma A/S DK0060257814 | 🇩🇰 DK | $3,4 Mrd. | C |
| 107 | Telix Pharmaceuticals Limited AU000000TLX2 | 🇦🇺 AU | $3,4 Mrd. | D |
| 108 | Edgewise Therapeutics Inc. US28036F1057 | 🇺🇸 US | $3,4 Mrd. | D |
| 109 | Viking Therapeutics Inc. US92686J1060 | 🇺🇸 US | $3,3 Mrd. | D |
| 110 | Veracyte Inc. US92337F1075 | 🇺🇸 US | $3,3 Mrd. | B |
| 111 | Erasca Inc. US29479A1088 | 🇺🇸 US | $3,2 Mrd. | D |
| 112 | BioArctic AB (publ) SE0010323311 | 🇸🇪 SE | $2,9 Mrd. | B+ |
| 113 | Denali Therapeutics Inc. US24823R1059 | 🇺🇸 US | $2,9 Mrd. | D |
| 114 | Voronoi Inc. KR7310210000 | 🇷🇴 RO | $2,8 Mrd. | D |
| 115 | Soleno Therapeutics Inc. US8342033094 | 🇺🇸 US | $2,8 Mrd. | C |
| 116 | Beam Therapeutics Inc. US07373V1052 | 🇺🇸 US | $2,8 Mrd. | D |
| 117 | Dyne Therapeutics Inc. US26818M1080 | 🇺🇸 US | $2,7 Mrd. | D |
| 118 | Tarsus Pharmaceuticals Inc. US87650L1035 | 🇺🇸 US | $2,7 Mrd. | C |
| 119 | Alumis Inc. Common Stock US0223071020 | 🇺🇸 US | $2,6 Mrd. | D |
| 120 | Disc Medicine Inc. US2546041011 | 🇺🇸 US | $2,6 Mrd. | D |
| 121 | Duality Biotherapeutics Inc. KYG2929M1087 | 🇨🇳 CN | $2,5 Mrd. | D |
| 122 | AnaptysBio Inc. US0327241065 | 🇺🇸 US | $2,5 Mrd. | C |
| 123 | Arcutis Biotherapeutics Inc. US03969K1088 | 🇺🇸 US | $2,5 Mrd. | D |
| 124 | IDEAYA Biosciences Inc. US45166A1025 | 🇺🇸 US | $2,5 Mrd. | D |
| 125 | Vera Therapeutics Inc. US92337R1014 | 🇺🇸 US | $2,5 Mrd. | D |
| 126 | Enliven Therapeutics Inc. US29337E1029 | 🇺🇸 US | $2,4 Mrd. | D |
| 127 | Nanobiotix S.A. FR0011341205 | 🇫🇷 FR | $2,4 Mrd. | D |
| 128 | Tango Therapeutics Inc. US87583X1090 | 🇺🇸 US | $2,4 Mrd. | D |
| 129 | Ultragenyx Pharmaceutical Inc. US90400D1081 | 🇺🇸 US | $2,4 Mrd. | D |
| 130 | Keymed Biosciences Inc. KYG5252B1023 | 🇨🇳 CN | $2,4 Mrd. | D |
| 131 | Arcus Biosciences Inc. US03969F1093 | 🇺🇸 US | $2,4 Mrd. | D |
| 132 | Bavarian Nordic A/S DK0015998017 | 🇩🇰 DK | $2,3 Mrd. | B+ |
| 133 | Relay Therapeutics Inc. US75943R1023 | 🇺🇸 US | $2,3 Mrd. | D |
| 134 | InnoCare Pharma Limited KYG4783B1032 | 🇨🇳 CN | $2,3 Mrd. | C |
| 135 | Definium Therapeutics Inc. CA24477V1058 | 🇺🇸 US | $2,2 Mrd. | D |
| 136 | Day One Biopharmaceuticals Inc. US23954D1090 | 🇺🇸 US | $2,2 Mrd. | D |
| 137 | Oruka Therapeutics Inc. US6876041087 | 🇺🇸 US | $2,2 Mrd. | D |
| 138 | Onesource Specialty Pharma Ltd. INE013P01021 | 🇮🇳 IN | $2,2 Mrd. | D |
| 139 | Tyra Biosciences Inc. US90240B1061 | 🇺🇸 US | $2,1 Mrd. | D |
| 140 | Ascletis Pharma Inc. KYG0520K1094 | 🇨🇳 CN | $2,1 Mrd. | D |
| 141 | Zai Lab Limited KYG9887T1168 | 🇨🇳 CN | $2,1 Mrd. | D |
| 142 | SK bioscience Co.Ltd. KR7302440003 | 🇰🇷 KR | $2,1 Mrd. | D |
| 143 | Genus plc GB0002074580 | 🇬🇧 GB | $2,1 Mrd. | C |
| 144 | PharmaResearch Co. Ltd. KR7214450009 | 🇰🇷 KR | $2,1 Mrd. | C |
| 145 | Structure Therapeutics Inc. US86366E1064 | 🇺🇸 US | $2,1 Mrd. | D |
| 146 | Adaptive Biotechnologies Corporation US00650F1093 | 🇺🇸 US | $2,0 Mrd. | D |
| 147 | Syngene International Limited INE398R01022 | 🇮🇳 IN | $2,0 Mrd. | C |
| 148 | Celldex Therapeutics Inc. US15117B2025 | 🇺🇸 US | $2,0 Mrd. | D |
| 149 | Aurinia Pharmaceuticals Inc. CA05156V1022 | 🇨🇦 CA | $2,0 Mrd. | A |
| 150 | ADMA Biologics Inc. US0008991046 | 🇺🇸 US | $1,9 Mrd. | C |
| 151 | Pharma Mar S.A. ES0169501022 | 🇪🇸 ES | $1,9 Mrd. | B+ |
| 152 | Hugel Inc. KR7145020004 | 🇰🇷 KR | $1,9 Mrd. | C |
| 153 | Trevi Therapeutics Inc. US89532M1018 | 🇺🇸 US | $1,9 Mrd. | D |
| 154 | Immunome Inc. US45257U1088 | 🇺🇸 US | $1,9 Mrd. | D |
| 155 | Mesoblast Limited AU000000MSB8 | 🇦🇺 AU | $1,9 Mrd. | D |
| 156 | Pharvaris N.V. NL00150005Y4 | 🇳🇱 NL | $1,9 Mrd. | D |
| 157 | BioCryst Pharmaceuticals Inc. US09058V1035 | 🇺🇸 US | $1,9 Mrd. | D |
| 158 | Kodiak Sciences Inc. US50015M1099 | 🇺🇸 US | $1,9 Mrd. | D |
| 159 | Ocular Therapeutix Inc. US67576A1007 | 🇺🇸 US | $1,8 Mrd. | D |
| 160 | Ascentage Pharma Group International KYG0519B1023 | 🇨🇳 CN | $1,8 Mrd. | D |
| 161 | OliX PharmaceuticalsInc KR7226950004 | 🇰🇷 KR | $1,8 Mrd. | D |
| 162 | Stoke Therapeutics Inc. US86150R1077 | 🇺🇸 US | $1,8 Mrd. | D |
| 163 | Zymeworks Inc. US98985Y1082 | 🇨🇦 CA | $1,8 Mrd. | D |
| 164 | Sarepta Therapeutics Inc. US8036071004 | 🇺🇸 US | $1,8 Mrd. | D |
| 165 | Vericel Corporation US92346J1088 | 🇺🇸 US | $1,8 Mrd. | C |
| 166 | Sionna Therapeutics Inc. US8294011080 | 🇺🇸 US | $1,8 Mrd. | D |
| 167 | Mineralys Therapeutics Inc. US6031701013 | 🇺🇸 US | $1,7 Mrd. | D |
| 168 | Galapagos N.V. BE0003818359 | 🇧🇪 BE | $1,7 Mrd. | B+ |
| 169 | Harmony Biosciences Holdings Inc. US4131971040 | 🇺🇸 US | $1,7 Mrd. | B+ |
| 170 | Syndax Pharmaceuticals Inc. US87164F1057 | 🇺🇸 US | $1,7 Mrd. | D |
| 171 | D&D Pharmatech KR7347850000 | 🇰🇷 KR | $1,7 Mrd. | D |
| 172 | uniQure N.V. NL0010696654 | 🇳🇱 NL | $1,7 Mrd. | D |
| 173 | Agios Pharmaceuticals Inc. US00847X1046 | 🇺🇸 US | $1,7 Mrd. | D |
| 174 | Innoviva Inc. US45781M1018 | 🇺🇸 US | $1,6 Mrd. | A |
| 175 | Oculis Holding AG CH1242303498 | 🇨🇭 CH | $1,6 Mrd. | D |
| 176 | CStone Pharmaceuticals KYG2588M1006 | 🇨🇳 CN | $1,6 Mrd. | D |
| 177 | Oxford Nanopore Technologies plc GB00BP6S8Z30 | 🇬🇧 GB | $1,6 Mrd. | D |
| 178 | Inhibrx Biosciences Inc. US45720N1037 | 🇺🇸 US | $1,6 Mrd. | D |
| 179 | Ardelyx Inc. US0396971071 | 🇺🇸 US | $1,5 Mrd. | D |
| 180 | GH Research PLC IE000GID8VI0 | 🇮🇪 IE | $1,5 Mrd. | D |
| 181 | Vir Biotechnology Inc. US92764N1028 | 🇺🇸 US | $1,5 Mrd. | D |
| 182 | Novavax Inc. US6700024010 | 🇺🇸 US | $1,5 Mrd. | D |
| 183 | Nuvation Bio Inc. US67080N1019 | 🇺🇸 US | $1,5 Mrd. | D |
| 184 | Immunocore Holdings plc US45258D1054 | 🇬🇧 GB | $1,4 Mrd. | D |
| 185 | KalVista Pharmaceuticals Inc. US4834971032 | 🇺🇸 US | $1,4 Mrd. | D |
| 186 | Intellia Therapeutics Inc. US45826J1051 | 🇺🇸 US | $1,4 Mrd. | D |
| 187 | Immatics N.V. NL0015285941 | 🇩🇪 DE | $1,4 Mrd. | D |
| 188 | Everest Medicines Limited KYG3224E1061 | 🇨🇳 CN | $1,4 Mrd. | D |
| 189 | UroGen Pharma Ltd. IL0011407140 | 🇺🇸 US | $1,4 Mrd. | D |
| 190 | Viridian Therapeutics Inc. US92790C1045 | 🇺🇸 US | $1,4 Mrd. | D |
| 191 | Taysha Gene Therapies Inc. US8776191061 | 🇺🇸 US | $1,4 Mrd. | D |
| 192 | Maze Therapeutics Inc. US5787841007 | 🇺🇸 US | $1,4 Mrd. | D |
| 193 | Nurix Therapeutics Inc. US67080M1036 | 🇺🇸 US | $1,3 Mrd. | D |
| 194 | Nektar Therapeutics US6402683063 | 🇺🇸 US | $1,3 Mrd. | D |
| 195 | HBM Holdings Limited KYG4403H1002 | 🇨🇳 CN | $1,3 Mrd. | C |
| 196 | Capricor Therapeutics Inc. US14070B3096 | 🇺🇸 US | $1,3 Mrd. | D |
| 197 | Recursion Pharmaceuticals Inc. US75629V1044 | 🇺🇸 US | $1,3 Mrd. | D |
| 198 | CARsgen Therapeutics Holdings Limited KYG1996C1006 | 🇨🇳 CN | $1,3 Mrd. | D |
| 199 | Fortrea Holdings Inc. US34965K1079 | 🇺🇸 US | $1,3 Mrd. | D |
| 200 | Rapport Therapeutics Inc. Common Stock US75383L1026 | 🇺🇸 US | $1,3 Mrd. | D |
| 201 | AbCellera Biologics Inc. CA00288U1066 | 🇨🇦 CA | $1,3 Mrd. | D |
| 202 | ArriVent BioPharma Inc. Common Stock US04272N1028 | 🇺🇸 US | $1,3 Mrd. | D |
| 203 | Palvella Therapeutics Inc. US6979471090 | 🇺🇸 US | $1,2 Mrd. | D |
| 204 | Concord Biotech Limited INE338H01029 | 🇮🇳 IN | $1,2 Mrd. | C |
| 205 | Wave Life Sciences Ltd. SG9999014716 | 🇸🇬 SG | $1,2 Mrd. | D |
| 206 | Precigen Inc. US74017N1054 | 🇺🇸 US | $1,2 Mrd. | D |
| 207 | Iovance Biotherapeutics Inc. US4622601007 | 🇺🇸 US | $1,2 Mrd. | D |
| 208 | MoonLake Immunotherapeutics KY61559X1045 | 🇨🇭 CH | $1,2 Mrd. | D |
| 209 | Septerna Inc. US81734D1046 | 🇺🇸 US | $1,2 Mrd. | D |
| 210 | Monte Rosa Therapeutics Inc. US61225M1027 | 🇺🇸 US | $1,2 Mrd. | D |
| 211 | Maravai LifeSciences Holdings Inc. US56600D1072 | 🇺🇸 US | $1,1 Mrd. | D |
| 212 | Idorsia Ltd CH0363463438 | 🇨🇭 CH | $1,1 Mrd. | D |
| 213 | Neuren Pharmaceuticals Limited NZNEUE0001S8 | 🇦🇺 AU | $1,1 Mrd. | D |
| 214 | Olema Pharmaceuticals Inc. US68062P1066 | 🇺🇸 US | $1,1 Mrd. | D |
| 215 | Lepu Biopharma Co. Ltd. CNE100004SM4 | 🇨🇳 CN | $1,1 Mrd. | D |
| 216 | Amylyx Pharmaceuticals Inc. US03237H1014 | 🇺🇸 US | $1,1 Mrd. | D |
| 217 | Alphamab Oncology KYG0330A1013 | 🇨🇳 CN | $1,1 Mrd. | D |
| 218 | Bicara Therapeutics Inc. Common Stock US0554771032 | 🇺🇸 US | $1,1 Mrd. | D |
| 219 | MBX Biosciences Inc. Common Stock US55287L1017 | 🇺🇸 US | $1,0 Mrd. | D |
| 220 | SELLAS Life Sciences Group Inc. US81642T2096 | 🇺🇸 US | $1,0 Mrd. | D |
| 221 | Xeris Biopharma Holdings Inc. US98422E1038 | 🇺🇸 US | $1,0 Mrd. | D |
| 222 | Corvus Pharmaceuticals Inc. US2210151005 | 🇺🇸 US | $1,0 Mrd. | D |
| 223 | Kuros Biosciences AG CH0325814116 | 🇨🇭 CH | $1,0 Mrd. | D |
| 224 | Savara Inc. US8051111016 | 🇺🇸 US | $1,0 Mrd. | D |
| 225 | GNI Group Ltd. JP3386370005 | 🇯🇵 JP | $990 Mio. | D |
| 226 | Oxford Biomedica plc GB00BDFBVT43 | 🇬🇧 GB | $988 Mio. | D |
| 227 | EyePoint Pharmaceuticals Inc. US30233G2093 | 🇺🇸 US | $981 Mio. | D |
| 228 | PeptiDream Inc. JP3836750004 | 🇯🇵 JP | $930 Mio. | D |
| 229 | MannKind Corporation US56400P7069 | 🇺🇸 US | $924 Mio. | D |
| 230 | Phathom Pharmaceuticals Inc. US71722W1071 | 🇺🇸 US | $908 Mio. | D |
| 231 | Biohaven Ltd. VGG1110E1079 | 🇺🇸 US | $899 Mio. | D |
| 232 | Pharming Group N.V. NL0010391025 | 🇳🇱 NL | $893 Mio. | D |
| 233 | Eton Pharmaceuticals Inc. US29772L1089 | 🇺🇸 US | $890 Mio. | C |
| 234 | Alpha Tau Medical Ltd. IL0011839383 | 🇮🇱 IL | $883 Mio. | D |
| 235 | MeiraGTx Holdings plc KYG596651029 | 🇺🇸 US | $871 Mio. | D |
| 236 | Takara Bio Inc. JP3460200003 | 🇯🇵 JP | $865 Mio. | D |
| 237 | Abbisko Cayman Limited KYG0028A1085 | 🇨🇳 CN | $864 Mio. | C |
| 238 | Janux Therapeutics Inc. US47103J1051 | 🇺🇸 US | $856 Mio. | D |
| 239 | OPKO Health Inc. US68375N1037 | 🇺🇸 US | $853 Mio. | D |
| 240 | Omeros Corporation US6821431029 | 🇺🇸 US | $847 Mio. | C |
| 241 | Sana Biotechnology Inc. US7995661045 | 🇺🇸 US | $846 Mio. | D |
| 242 | Basilea Pharmaceutica AG CH0011432447 | 🇨🇭 CH | $841 Mio. | C |
| 243 | Theravance Biopharma Inc. KYG8807B1068 | 🇰🇾 KY | $838 Mio. | D |
| 244 | Gubra A/S DK0062266474 | 🇩🇰 DK | $838 Mio. | B |
| 245 | SanBio Company Limited JP3336750009 | 🇯🇵 JP | $824 Mio. | D |
| 246 | Arbutus Biopharma Corporation CA03879J1003 | 🇺🇸 US | $824 Mio. | D |
| 247 | ORIC Pharmaceuticals Inc. US68622P1093 | 🇺🇸 US | $821 Mio. | D |
| 248 | Xencor Inc. US98401F1057 | 🇺🇸 US | $820 Mio. | D |
| 249 | Kura Oncology Inc. US50127T1097 | 🇺🇸 US | $817 Mio. | D |
| 250 | Geron Corporation US3741631036 | 🇺🇸 US | $789 Mio. | D |
| 251 | Absci Corporation US00091E1091 | 🇺🇸 US | $771 Mio. | D |
| 252 | Oneness Biotech Co. Ltd. TW0004743000 | 🇹🇼 TW | $770 Mio. | D |
| 253 | Alto Neuroscience Inc. US02157Q1094 | 🇺🇸 US | $765 Mio. | D |
| 254 | Zenas BioPharma Inc. US98937L1052 | 🇺🇸 US | $755 Mio. | D |
| 255 | ARS Pharmaceuticals Inc. US82835W1080 | 🇺🇸 US | $725 Mio. | D |
| 256 | Jade Biosciences Inc. US0080642061 | 🇺🇸 US | $718 Mio. | D |
| 257 | Clarity Pharmaceuticals Ltd AU0000165375 | 🇦🇺 AU | $710 Mio. | D |
| 258 | Chabiotech Co.Ltd. KR7085660009 | 🇰🇷 KR | $699 Mio. | D |
| 259 | Design Therapeutics Inc. US25056L1035 | 🇺🇸 US | $668 Mio. | D |
| 260 | Nxera Pharma Co. Ltd. JP3431300007 | 🇯🇵 JP | $662 Mio. | D |
| 261 | Bright Minds Biosciences Inc. CA10919W4056 | 🇨🇦 CA | $657 Mio. | D |
| 262 | Esperion Therapeutics Inc. US29664W1053 | 🇺🇸 US | $651 Mio. | D |
| 263 | Ocumension Therapeutics KYG674111011 | 🇨🇳 CN | $650 Mio. | D |
| 264 | Pharmicell Co. Ltd. KR7005690003 | 🇰🇷 KR | $623 Mio. | C |
| 265 | CorMedix Inc. US21900C3088 | 🇺🇸 US | $621 Mio. | C |
| 266 | Zevra Therapeutics Inc. US4884452065 | 🇺🇸 US | $617 Mio. | B+ |
| 267 | Annexon Inc. US03589W1027 | 🇺🇸 US | $593 Mio. | D |
| 268 | BioAge Labs Inc. US09077V1008 | 🇺🇸 US | $578 Mio. | D |
| 269 | Arvinas Inc. US04335A1051 | 🇺🇸 US | $566 Mio. | D |
| 270 | CytomX Therapeutics Inc. US23284F1057 | 🇺🇸 US | $563 Mio. | D |
| 271 | MiMedx Group Inc. US6024961012 | 🇺🇸 US | $535 Mio. | C |
| 272 | Aclaris Therapeutics Inc. US00461U1051 | 🇺🇸 US | $531 Mio. | D |
| 273 | Rigel Pharmaceuticals Inc. US7665597024 | 🇺🇸 US | $529 Mio. | B+ |
| 274 | Tectonic Therapeutic Inc. US8789721086 | 🇺🇸 US | $523 Mio. | D |
| 275 | XOMA Royalty Corp. US98419J2069 | 🇺🇸 US | $522 Mio. | D |
| 276 | Prime Medicine Inc. US74168J1016 | 🇺🇸 US | $508 Mio. | D |
| 277 | Solid Biosciences Inc. US83422E2046 | 🇺🇸 US | $507 Mio. | D |
| 278 | Prothena Corporation plc IE00B91XRN20 | 🇮🇪 IE | $502 Mio. | D |
| 279 | Polaris Group KYG7171A1085 | 🇺🇸 US | $484 Mio. | D |
| 280 | Candel Therapeutics Inc. US1374041093 | 🇺🇸 US | $481 Mio. | D |
| 281 | Ginkgo Bioworks Holdings Inc. US37611X2099 | 🇺🇸 US | $481 Mio. | D |
| 282 | Aura Biosciences Inc. US05153U1079 | 🇺🇸 US | $480 Mio. | D |
| 283 | Allogene Therapeutics Inc. US0197701065 | 🇺🇸 US | $473 Mio. | D |
| 284 | Relmada Therapeutics Inc. US75955J4022 | 🇺🇸 US | $465 Mio. | D |
| 285 | Upstream Bio Inc. US91678A1079 | 🇺🇸 US | $463 Mio. | D |
| 286 | DBV Technologies S.A. US23306J3095 | 🇫🇷 FR | $449 Mio. | D |
| 287 | Neurogene Inc. US64135M1053 | 🇺🇸 US | $442 Mio. | D |
| 288 | 4D Molecular Therapeutics Inc. US35104E1001 | 🇺🇸 US | $437 Mio. | D |
| 289 | GI Innovation Inc. KR7358570000 | 🇰🇷 KR | $435 Mio. | D |
| 290 | Medy-Tox Inc. KR7086900008 | 🇰🇷 KR | $433 Mio. | D |
| 291 | Green Cross Holdings Corporation KR7005250006 | 🇰🇷 KR | $433 Mio. | D |
| 292 | TaiMed Biologics Inc. TW0004147004 | 🇹🇼 TW | $429 Mio. | D |
| 293 | Emergent BioSolutions Inc. US29089Q1058 | 🇺🇸 US | $419 Mio. | D |
| 294 | EirGenix Inc. TW0006589005 | 🇹🇼 TW | $419 Mio. | D |
| 295 | Replimune Group Inc. US76029N1063 | 🇺🇸 US | $414 Mio. | D |
| 296 | ADC Therapeutics S.A. CH0499880968 | 🇨🇭 CH | $403 Mio. | D |
| 297 | Greenwich LifeSciences Inc. US3968791083 | 🇺🇸 US | $377 Mio. | D |
| 298 | Monopar Therapeutics Inc. US61023L2079 | 🇺🇸 US | $377 Mio. | D |
| 299 | Kyverna Therapeutics Inc. US5019761049 | 🇺🇸 US | $374 Mio. | D |
| 300 | Lexeo Therapeutics Inc. Common Stock US52886X1072 | 🇺🇸 US | $370 Mio. | D |
| 301 | Vanda Pharmaceuticals Inc. US9216591084 | 🇺🇸 US | $366 Mio. | D |
| 302 | Puma Biotechnology Inc. US74587V1070 | 🇺🇸 US | $347 Mio. | C |
| 303 | Rocket Pharmaceuticals Inc. US77313F1066 | 🇺🇸 US | $335 Mio. | D |
| 304 | Atea Pharmaceuticals Inc. US04683R1068 | 🇺🇸 US | $331 Mio. | D |
| 305 | Fulcrum Therapeutics Inc. US3596161097 | 🇺🇸 US | $330 Mio. | D |
| 306 | Keros Therapeutics Inc. US4923271013 | 🇺🇸 US | $325 Mio. | D |
| 307 | Enanta Pharmaceuticals Inc. US29251M1062 | 🇺🇸 US | $312 Mio. | D |
| 308 | Rezolute Inc. US76200L3096 | 🇺🇸 US | $312 Mio. | D |
| 309 | Niagen Bioscience Inc US1710774076 | 🇺🇸 US | $307 Mio. | D |
| 310 | Abeona Therapeutics Inc. US00289Y2063 | 🇺🇸 US | $306 Mio. | C |
| 311 | Verastem Inc. US92337C2035 | 🇺🇸 US | $295 Mio. | D |
| 312 | REGENXBIO Inc. US75901B1070 | 🇺🇸 US | $292 Mio. | D |
| 313 | Benitec Biopharma Inc. US08205P2092 | 🇺🇸 US | $286 Mio. | D |
| 314 | Larimar Therapeutics Inc. US5171251003 | 🇺🇸 US | $277 Mio. | D |
| 315 | OmniAb Inc. US68218J1034 | 🇺🇸 US | $273 Mio. | D |
| 316 | Akebia Therapeutics Inc. US00972D1054 | 🇺🇸 US | $271 Mio. | D |
| 317 | Anavex Life Sciences Corp. US0327973006 | 🇺🇸 US | $267 Mio. | D |
| 318 | Achieve Life Sciences Inc. US0044685008 | 🇨🇦 CA | $255 Mio. | D |
| 319 | Compass Therapeutics Inc. US20454B1044 | 🇺🇸 US | $253 Mio. | D |
| 320 | Editas Medicine Inc. US28106W1036 | 🇺🇸 US | $248 Mio. | D |
| 321 | Altimmune Inc. US02155H2004 | 🇺🇸 US | $247 Mio. | D |
| 322 | Alector Inc. US0144421072 | 🇺🇸 US | $235 Mio. | D |
| 323 | Codexis Inc. US1920051067 | 🇺🇸 US | $232 Mio. | D |
| 324 | Entrada Therapeutics Inc. US29384C1080 | 🇺🇸 US | $229 Mio. | D |
| 325 | Tonix Pharmaceuticals Holding Corp. US8902608392 | 🇺🇸 US | $227 Mio. | D |
| 326 | Foghorn Therapeutics Inc. US3441741077 | 🇺🇸 US | $224 Mio. | D |
| 327 | Caribou Biosciences Inc. US1420381089 | 🇺🇸 US | $221 Mio. | D |
| 328 | LENZ Therapeutics Inc. US52635N1037 | 🇺🇸 US | $216 Mio. | D |
| 329 | Eledon Pharmaceuticals Inc. US28617K1016 | 🇺🇸 US | $215 Mio. | D |
| 330 | Voyager Therapeutics Inc. US92915B1061 | 🇺🇸 US | $213 Mio. | D |
| 331 | Fate Therapeutics Inc. US31189P1021 | 🇺🇸 US | $202 Mio. | D |
| 332 | BINEX Co. Ltd. KR7053030003 | 🇰🇷 KR | $200 Mio. | D |
| 333 | Arcturus Therapeutics Holdings Inc. US03969T1097 | 🇺🇸 US | $200 Mio. | D |
| 334 | Nkarta Inc. US65487U1088 | 🇺🇸 US | $192 Mio. | D |
| 335 | Coherus Oncology Inc. US19249H1032 | 🇺🇸 US | $182 Mio. | D |
| 336 | MediWound Ltd. IL0011316309 | 🇮🇱 IL | $178 Mio. | D |
| 337 | Protara Therapeutics Inc. US74365U1079 | 🇺🇸 US | $178 Mio. | D |
| 338 | Quantum-Si incorporated US74765K1051 | 🇺🇸 US | $169 Mio. | D |
| 339 | Protalix BioTherapeutics Inc. US74365A3095 | 🇺🇸 US | $154 Mio. | D |
| 340 | Humacyte Inc. US44486Q1031 | 🇺🇸 US | $151 Mio. | D |
| 341 | Onconic Therapeutics KR7476060009 | 🇰🇷 KR | $144 Mio. | C |
| 342 | Heron Therapeutics Inc. US4277461020 | 🇺🇸 US | $136 Mio. | D |
| 343 | Milestone Pharmaceuticals Inc. CA59935V1076 | 🇨🇦 CA | $125 Mio. | D |
| 344 | Inhibikase Therapeutics Inc. US45719W2052 | 🇺🇸 US | $123 Mio. | D |
| 345 | Vor Biopharma Inc. US9290332074 | 🇺🇸 US | $115 Mio. | D |
| 346 | Aldeyra Therapeutics Inc. US01438T1060 | 🇺🇸 US | $97 Mio. | D |
| 347 | Aardvark Therapeutics Inc. Common Stock US0029421007 | 🇺🇸 US | $95 Mio. | D |
| 348 | NRx Pharmaceuticals Inc. US6294442099 | 🇺🇸 US | $54 Mio. | D |
| 349 | Gossamer Bio Inc. US38341P1021 | 🇺🇸 US | $45 Mio. | D |
| 350 | LeonaBio Inc. US04746L2034 | 🇺🇸 US | $40 Mio. | D |
| 351 | Pasithea Therapeutics Corp. US70261F2020 | 🇺🇸 US | $5 Mio. | D |